Carlsmed, Inc. To Participate in the J.P. Morgan 2026 Healthcare Conference
Carlsmed (NASDAQ:CARL) had its "buy" rating reaffirmed by analysts at BTIG Research.
Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting
Carlsmed (NASDAQ:CARL) had its "sell (e)" rating reaffirmed by analysts at
Weiss Ratings.
Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]